KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) EBT: 2009-2024

Historic EBT for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $1.1 billion.

  • Idexx Laboratories' EBT rose 15.34% to $344.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 16.51%. This contributed to the annual value of $1.1 billion for FY2024, which is 4.59% up from last year.
  • According to the latest figures from FY2024, Idexx Laboratories' EBT is $1.1 billion, which was up 4.59% from $1.1 billion recorded in FY2023.
  • Idexx Laboratories' EBT's 5-year high stood at $1.1 billion during FY2024, with a 5-year trough of $662.0 million in FY2020.
  • For the 3-year period, Idexx Laboratories' EBT averaged around $1.0 billion, with its median value being $1.1 billion (2023).
  • As far as peak fluctuations go, Idexx Laboratories' EBT spiked by 36.36% in 2021, and later fell by 4.73% in 2022.
  • Idexx Laboratories' EBT (Yearly) stood at $662.0 million in 2020, then surged by 36.36% to $902.7 million in 2021, then decreased by 4.73% to $860.0 million in 2022, then rose by 23.40% to $1.1 billion in 2023, then climbed by 4.59% to $1.1 billion in 2024.